期刊
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
卷 11, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fcimb.2021.596201
关键词
SARS-CoV-2; COVID-19; coronaviruses; transmission; diagnostics; therapeutics
资金
- Indian Council of Medical Research
- THSTI Faridabad
COVID-19 is a severe acute respiratory syndrome caused by SARS-CoV-2, a novel virus that has spread globally with higher infectivity and mortality compared to its earlier relatives. Understanding potential transmission routes and rapidly developed diagnostics are crucial in managing the disease.
COVID-19 is a Severe Acute Respiratory Syndrome (SARS), caused by SARS-CoV-2, a novel virus which belongs to the family Coronaviridae. It was first reported in December 2019 in the Wuhan city of China and soon after, the virus and hence the disease got spread to the entire world. As of February 26, 2021, SARS-CoV-2 has infected similar to 112.20 million people and caused similar to 2.49 million deaths across the globe. Although the case fatality rate among SARS-CoV-2 patient is lower (similar to 2.15%) than its earlier relatives, SARS-CoV (similar to 9.5%) and MERS-CoV (similar to 34.4%), the SARS-CoV-2 has been observed to be more infectious and caused higher morbidity and mortality worldwide. As of now, only the knowledge regarding potential transmission routes and the rapidly developed diagnostics has been guiding the world for managing the disease indicating an immediate need for a detailed understanding of the pathogen and the disease-biology. Over a very short period of time, researchers have generated a lot of information in unprecedented ways in the key areas, including viral entry into the host, dominant mutation, potential transmission routes, diagnostic targets and their detection assays, potential therapeutic targets and drug molecules for inhibiting viral entry and/or its replication in the host including cross-neutralizing antibodies and vaccine candidates that could help us to combat the ongoing COVID-19 pandemic. In the current review, we have summarized the available knowledge about the pathogen and the disease, COVID-19. We believe that this readily available knowledge base would serve as a valuable resource to the scientific and clinical community and may help in faster development of the solution to combat the disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据